VolitionRX

$4.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (+3.76%) Today
-$0.02 (-0.45%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VolitionRX and other stocks, options, and ETFs commission-free!

About VNRX

VolitionRX Limited Common Stock, also called VolitionRX, is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX. The listed name for VNRX is VolitionRX Limited Common Stock.

CEO
Cameron John Reynolds
Employees
50
Headquarters
Austin, Texas
Founded
2010
Market Cap
221.70M
Price-Earnings Ratio
Dividend Yield
Average Volume
976.64K
High Today
$4.57
Low Today
$4.31
Open Price
$4.31
Volume
396.45K
52 Week High
$6.67
52 Week Low
$2.22

VNRX Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 9, After Hours

You May Also Like

BCPC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure